TCF1 deficiency ameliorates autoimmune lymphoproliferative syndrome (ALPS)‐like phenotypes of lpr/lpr mice
Sign Up to like & getrecommendations! Published in 2017 at "Scandinavian Journal of Immunology"
DOI: 10.1111/sji.12546
Abstract: Autoimmune lymphoproliferative syndrome (ALPS) is an incurable disease, which is characterized by non‐malignant autoimmune lymphoproliferation. TCF1 is a key effector in the canonical Wnt/β‐catenin pathway, regulating the development, activation and function of T cells. In… read more here.
Keywords: lpr mice; lpr lpr; tcf1 lpr; mice ... See more keywords